J. Jaubert

4.5k total citations
46 papers, 1.7k citations indexed

About

J. Jaubert is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, J. Jaubert has authored 46 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 14 papers in Pathology and Forensic Medicine and 13 papers in Oncology. Recurrent topics in J. Jaubert's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). J. Jaubert is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). J. Jaubert collaborates with scholars based in France, Réunion and United States. J. Jaubert's co-authors include B Desablens, Brigitte Dreyfus, M Leporrier, Karim Maloum, Bruno Cazin, Philippe Travade, Guillaume Dighiero, Jacques‐Louis Binet, Marine Diviné and G. Lepeu and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

J. Jaubert

43 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Jaubert France 15 879 829 473 431 356 46 1.7k
A. C. Parker United Kingdom 16 630 0.7× 394 0.5× 278 0.6× 432 1.0× 403 1.1× 57 1.3k
Katsuji Shinagawa Japan 27 259 0.3× 354 0.4× 591 1.2× 815 1.9× 428 1.2× 108 1.9k
Enrico Balleari Italy 23 399 0.5× 261 0.3× 368 0.8× 735 1.7× 439 1.2× 71 1.8k
Minnie Abromowitch United States 33 558 0.6× 838 1.0× 454 1.0× 1.1k 2.6× 147 0.4× 67 3.0k
Delvyn C. Case United States 17 404 0.5× 511 0.6× 306 0.6× 666 1.5× 108 0.3× 42 1.4k
Parameswaran Venugopal United States 21 482 0.5× 339 0.4× 684 1.4× 1.1k 2.4× 330 0.9× 130 1.9k
Ho‐Jin Shin South Korea 22 365 0.4× 691 0.8× 399 0.8× 944 2.2× 412 1.2× 182 2.0k
Janet Valdez United States 17 1.1k 1.2× 758 0.9× 223 0.5× 746 1.7× 608 1.7× 42 1.7k
Maria Cantonetti Italy 20 306 0.3× 571 0.7× 208 0.4× 279 0.6× 139 0.4× 84 1.2k
Pietro Pioltelli Italy 23 778 0.9× 302 0.4× 195 0.4× 969 2.2× 213 0.6× 80 2.0k

Countries citing papers authored by J. Jaubert

Since Specialization
Citations

This map shows the geographic impact of J. Jaubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jaubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jaubert more than expected).

Fields of papers citing papers by J. Jaubert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Jaubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jaubert. The network helps show where J. Jaubert may publish in the future.

Co-authorship network of co-authors of J. Jaubert

This figure shows the co-authorship network connecting the top 25 collaborators of J. Jaubert. A scholar is included among the top collaborators of J. Jaubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Jaubert. J. Jaubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bertolotti, A., et al.. (2017). Le typhus murin à l’Île de La Réunion, caractéristiques cliniques, biologiques et épidémiologiques. Annales de Dermatologie et de Vénéréologie. 144(12). S287–S287. 1 indexed citations
2.
Mounier, Nicolas, Pauline Brice, Serge Bologna, et al.. (2014). ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial. Annals of Oncology. 25(8). 1622–1628. 66 indexed citations
3.
Avet‐Loiseau, Hervé, Denis Caillot, Gérald Marit, et al.. (2010). Long-Term Maintenance with Lenalidomide Improves Progression Free Survival In Myeloma Patients with High-Risk Cytogenetics: An IFM Study. Blood. 116(21). 1944–1944. 13 indexed citations
4.
Simon, Audrey, Michel Péoc’h, Philippe Casassus, et al.. (2010). Upfront VIP‐reinforced‐ABVD (VIP‐rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS‐LTP95. British Journal of Haematology. 151(2). 159–166. 109 indexed citations
5.
Cazin, Bruno, Marine Diviné, Stéphane Leprêtre, et al.. (2008). High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia. British Journal of Haematology. 143(1). 54–59. 13 indexed citations
6.
Rousselot, Philippe, François Xavier Mahon, Delphine Réa, et al.. (2007). High Efficacy and Particular Safety Profile of Imatinib Mesylate (Glivec®) in Elderly Patients with CML in Chronic Phase: Results of the AFR04 Prospective Study.. Blood. 110(11). 1039–1039. 1 indexed citations
7.
Fermé, Christophe, Marine Diviné, Andrej Vranovský, et al.. (2005). Four ABVD and Involved-Field Radiotherapy in Unfavorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-U Trial.. Blood. 106(11). 813–813. 24 indexed citations
8.
Vial, Thierry, C. Guy, M. Zénut, et al.. (2004). Sideroblastic anaemia during fusidic acid treatment. European Journal Of Haematology. 72(5). 358–360. 3 indexed citations
9.
Dumontet, Charles, J. Jaubert, Catherine Sebban, et al.. (2003). Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patients. Annals of Oncology. 14(4). 615–622. 7 indexed citations
10.
Boudard, Delphine, C. Vasselon, J. Jaubert, et al.. (2002). Expression and prognostic significance of Bcl‐2 family proteins in myelodysplastic syndromes. American Journal of Hematology. 70(2). 115–125. 50 indexed citations
11.
Leporrier, M, Sylvie Chevret, Bruno Cazin, et al.. (2001). Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood. 98(8). 2319–2325. 298 indexed citations
12.
Dighiero, Guillaume, Karim Maloum, B Desablens, et al.. (1998). Chlorambucil in Indolent Chronic Lymphocytic Leukemia. New England Journal of Medicine. 338(21). 1506–1514. 323 indexed citations
13.
Rimokh, Ruth, C. Vasselon, Françoise Berger, et al.. (1992). t(2; 18) and t(18;22) Variant Chromosomal Translocations in B Cell Malignancies. Leukemia & lymphoma. 8(3). 197–200. 7 indexed citations
14.
Hafid, Jamal, et al.. (1991). Toxoplasma gondii antigens: Analysis by SDS-PAGE and immunoblotting; Relation with circulating antigens. European Journal of Protistology. 26(3-4). 303–307. 7 indexed citations
15.
Guérin, Christopher J., et al.. (1989). Errors in biochemical and haemodynamic data obtained using introducer lumen and proximal port of Swan Ganz catheter.. PubMed. 15(5). 330–1. 3 indexed citations
16.
Vindimian, M, et al.. (1989). Molecular diagnosis of chronic myeloid leukemia using a 3'bcr probe.. PubMed. 31(6). 393–5. 1 indexed citations
17.
Baklouti, Faouzi, Alain Francina, C. Périer, et al.. (1987). Hemoglobin Grange‐Blanche [β27(B9) Ala → Val], a new variant with normal expression and increased affinity for oxygen. FEBS Letters. 223(1). 59–62. 6 indexed citations
18.
Decousus, Hervé, Marine L. Croze, Françis Lévi, et al.. (1985). Circadian changes in anticoagulant effect of heparin infused at a constant rate.. BMJ. 290(6465). 341–344. 128 indexed citations
19.
Jaubert, J., et al.. (1982). [Chromosome anomalies in acute granular leukemias or acute nonlymphoid leukemias].. PubMed. 30(9). 769–74.
20.
Lenoir, Gilbert, et al.. (1981). Variant translocation in Burkitt's lymphoma: 8;22 translocation in a french patient with an Epstein-Barr virus-associated tumor. Cancer Genetics and Cytogenetics. 3(2). 149–153. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. C. Parker Breakdown of academic impact, for papers by Katsuji Shinagawa Breakdown of academic impact, for papers by Enrico Balleari Breakdown of academic impact, for papers by Minnie Abromowitch Breakdown of academic impact, for papers by Delvyn C. Case Breakdown of academic impact, for papers by Parameswaran Venugopal Breakdown of academic impact, for papers by Ho‐Jin Shin Breakdown of academic impact, for papers by Janet Valdez Breakdown of academic impact, for papers by Maria Cantonetti Breakdown of academic impact, for papers by Pietro Pioltelli
Rankless by CCL
2026